Education
About Us
Working with TipRanks
Follow Us
Sino Biopharmaceutical Ltd (DE:SMZ1)
FRANKFURT:SMZ1
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ¥ 28.87B | ¥ 26.20B | ¥ 26.03B | ¥ 26.86B | ¥ 23.65B |
| Gross Profit | ¥ 23.53B | ¥ 21.21B | ¥ 21.54B | ¥ 21.53B | ¥ 18.46B |
| Operating Income | ¥ 6.14B | ¥ 5.79B | ¥ 5.59B | ¥ 5.08B | ¥ 4.19B |
| EBITDA | ¥ 6.11B | ¥ 6.98B | ¥ 6.69B | ¥ 19.87B | ¥ 5.66B |
| Net Income | ¥ 3.50B | ¥ 2.33B | ¥ 2.54B | ¥ 14.61B | ¥ 2.77B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ¥ 14.60B | ¥ 14.12B | ¥ 16.92B | ¥ 15.79B | ¥ 16.43B |
| Total Assets | ¥ 65.41B | ¥ 63.60B | ¥ 64.06B | ¥ 60.54B | ¥ 47.21B |
| Total Debt | ¥ 9.78B | ¥ 12.58B | ¥ 13.98B | ¥ 12.12B | ¥ 14.21B |
| Net Debt | ¥ 214.26M | ¥ 3.13B | ¥ 5.33B | ¥ 2.52B | ¥ 3.59B |
| Total Liabilities | ¥ 22.63B | ¥ 25.43B | ¥ 26.12B | ¥ 22.81B | ¥ 24.79B |
| Stockholders' Equity | ¥ 31.96B | ¥ 30.47B | ¥ 29.75B | ¥ 30.29B | ¥ 16.75B |
| Cash Flow | |||||
| Free Cash Flow | ¥ 5.22B | ¥ 4.36B | ¥ 4.56B | ¥ 3.47B | ¥ 3.47B |
| Operating Cash Flow | ¥ 6.62B | ¥ 6.07B | ¥ 6.27B | ¥ 5.37B | ¥ 5.33B |
| Investing Cash Flow | ¥ -1.71B | ¥ -756.98M | ¥ -4.07B | ¥ -2.52B | ¥ -7.85B |
| Financing Cash Flow | ¥ -6.32B | ¥ -6.55B | ¥ -3.19B | ¥ -3.23B | ¥ 2.23B |